We are live on ! Find out more
ACM

Accent Capital Management Portfolio holdings

AUM $206M
1-Year Est. Return 29.56%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+29.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$26.4M
Cap. Flow
-$7.39M
Cap. Flow %
-3.58%
Top 10 Hldgs %
69.38%
Holding
412
New
65
Increased
63
Reduced
65
Closed
78

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$95.3K
2
ASML icon
ASML
ASML
+$78.1K
3
AZN icon
AstraZeneca
AZN
+$78.1K
4
VTI icon
Vanguard Total Stock Market ETF
VTI
+$72.8K
5
NVS icon
Novartis
NVS
+$69.6K

Sector Composition

Rank Sector Weight
1 Technology 36.33%
2 Communication Services 18.36%
3 Consumer Discretionary 11.2%
4 Financials 8.78%
5 Consumer Staples 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWC icon
276
iShares Micro-Cap ETF
IWC
$1.43B
$958 ﹤0.01%
+6
New +$995
ACIW icon
277
ACI Worldwide
ACIW
$5.72B
-132
Closed -$6.31K
AKTX
278
Akari Therapeutics
AKTX
$15.2M
-125
Closed -$1.45K
AL
279
DELISTED
Air Lease Corp
AL
-90
Closed -$5.8K
AMRX icon
280
Amneal Pharmaceuticals
AMRX
$5.72B
-600
Closed -$7.56K
ANGO icon
281
AngioDynamics
ANGO
$562M
-260
Closed -$3.34K
BAM icon
282
Brookfield Asset Management
BAM
$74B
-106
Closed -$5.55K
BGC icon
283
BGC Group
BGC
$5.58B
-817
Closed -$7.3K
BMY icon
284
Bristol-Myers Squibb
BMY
$127B
-129
Closed -$6.96K
CLX icon
285
Clorox
CLX
$11.6B
-11
Closed -$1.11K
CNI icon
286
Canadian National Railway
CNI
$78.3B
-178
Closed -$17.6K
CP icon
287
Canadian Pacific Kansas City
CP
$82B
-8,750
Closed -$646K
CRSP icon
288
CRISPR Therapeutics
CRSP
$4.58B
-60
Closed -$3.15K
CRVL icon
289
CorVel
CRVL
$3.05B
-66
Closed -$4.47K
CSGP icon
290
CoStar Group
CSGP
$11.3B
-38
Closed -$2.56K
DKNG icon
291
DraftKings
DKNG
$11.4B
-121
Closed -$4.17K
DSGX icon
292
Descartes Systems
DSGX
$5.84B
-343
Closed -$30.1K
EA icon
293
Electronic Arts
EA
$52.4B
-150
Closed -$30.6K
FRSH icon
294
Freshworks
FRSH
$2.84B
-526
Closed -$6.44K
GFF icon
295
Griffon
GFF
$4.16B
-103
Closed -$7.59K
GTLS
296
DELISTED
Chart Industries
GTLS
-50
Closed -$10.3K
HALO icon
297
Halozyme
HALO
$9.72B
-101
Closed -$6.8K
HDB icon
298
HDFC Bank
HDB
$119B
-918
Closed -$33.5K
IBN icon
299
ICICI Bank
IBN
$106B
-886
Closed -$26.4K
IRTC icon
300
iRhythm Holdings
IRTC
$3.59B
-50
Closed -$8.87K

Similar funds

Accent Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Accent Capital Management held 412 positions worth $206M, down 11% from $233M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Accent Capital Management withdrew a net $7.39M in Q1 2026, closing 78 positions and reducing 65 holdings. Its most notable exit was UnitedHealth, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Accent Capital Management opened a new position in Novartis worth $69.3K.

  • Accent Capital Management's largest Q1 2026 buy was Novartis: 454 shares worth $69.3K.
  • Accent Capital Management added most to TSMC in Q1 2026, an estimated $95.3K increase.
  • Accent Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $1.37M.
  • Accent Capital Management fully exited UnitedHealth in Q1 2026, selling an estimated $2.17M.
  • Accent Capital Management's ten largest holdings make up 69% of its $206M portfolio in Q1 2026.
  • Accent Capital Management opened 65 new positions and closed 78 in Q1 2026.
  • Accent Capital Management's portfolio value fell 11% quarter-over-quarter to $206M.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.